Behcet's Disease: New Concepts in Cardiovascular Involvements and Future Direction for Treatment

M B Owlia1, G Mehrpoor

  • 1Division of Rheumatology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

ISRN Pharmacology
|April 25, 2012
PubMed

Insights

Behcet's disease is a rare vasculitis affecting arteries and veins. This review analyzes its cardiovascular impact, thrombosis, and future treatments for better patient outcomes.

Area of Science:

  • Rheumatology
  • Cardiovascular Medicine
  • Immunology

Background:

  • Behcet's disease (BD) is a unique systemic vasculitis affecting both arteries and veins of all sizes.
  • It presents significant morbidity and mortality, often seen in rheumatology clinics.
  • Understanding BD's cardiovascular manifestations is crucial for patient management.

Purpose of the Study:

  • To review the pathophysiology of Behcet's disease, with a focus on cardiovascular involvement.
  • To analyze current treatment strategies for cardiovascular complications and thrombosis in BD.
  • To explore potential future therapeutic avenues for Behcet's disease.

Main Methods:

  • Literature review of pathophysiology and treatment options for Behcet's disease.
  • Focus on cardiovascular aspects, including thrombosis.
  • Analysis of current and emerging treatment modalities.

Main Results:

  • Behcet's disease involves complex inflammatory pathways affecting vasculature.
  • Cardiovascular complications, including thrombosis, are major causes of morbidity and mortality.
  • Current treatments target inflammation and thrombosis, but novel approaches are needed.

Conclusions:

  • Behcet's disease requires a multidisciplinary approach, particularly for cardiovascular management.
  • Effective control of inflammation and thrombosis is key to improving outcomes.
  • Future research should focus on targeted therapies for Behcet's disease and its vascular complications.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...